BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 31670268)

  • 1. Improving survival with tuberculosis & HIV treatment integration: A mini-review.
    Naidoo K; Rampersad S; Karim SA
    Indian J Med Res; 2019 Aug; 150(2):131-138. PubMed ID: 31670268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.
    Sileshi B; Deyessa N; Girma B; Melese M; Suarez P
    BMC Infect Dis; 2013 Jul; 13():297. PubMed ID: 23815342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients: A Systematic Review and Meta-Analysis.
    Abay SM; Deribe K; Reda AA; Biadgilign S; Datiko D; Assefa T; Todd M; Deribew A
    J Int Assoc Provid AIDS Care; 2015; 14(6):560-70. PubMed ID: 26289343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TB-HIV co-infection among pregnant women in Karnataka, South India: A case series.
    Suresh S; Sharath BN; Anita S; Lalitha R; Prasad TJ; Rewari BB
    J Infect Public Health; 2016; 9(4):465-70. PubMed ID: 26711476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia.
    Wondmagegn T; Damtie D; Genetu M; Biadgo B; Lemma M; Negash M
    BMC Infect Dis; 2020 Feb; 20(1):109. PubMed ID: 32033581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.
    Worodria W; Ssempijja V; Hanrahan C; Ssegonja R; Muhofwa A; Mazapkwe D; Mayanja-Kizza H; Reynolds SJ; Colebunders R; Manabe YC
    AIDS; 2018 Sep; 32(15):2141-2149. PubMed ID: 30005014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
    Auld AF; Kerkhoff AD; Hanifa Y; Wood R; Charalambous S; Liu Y; Agizew T; Mathoma A; Boyd R; Date A; Shiraishi RW; Bicego G; Mathebula-Modongo U; Alexander H; Serumola C; Rankgoane-Pono G; Pono P; Finlay A; Shepherd JC; Ellerbrock TV; Grant AD; Fielding K
    PLoS Med; 2021 Sep; 18(9):e1003739. PubMed ID: 34491987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai University Hospital, Thailand.
    Limmahakhun S; Chaiwarith R; Nuntachit N; Sirisanthana T; Supparatpinyo K
    Int J STD AIDS; 2012 Jun; 23(6):414-8. PubMed ID: 22807535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current issues in the diagnosis and management of tuberculosis and HIV coinfection in the United States.
    Luetkemeyer AF
    Top HIV Med; 2010; 18(4):143-8. PubMed ID: 21107014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol.
    Naidoo K; Gengiah S; Yende-Zuma N; Padayatchi N; Barker P; Nunn A; Subrayen P; Abdool Karim SS
    Implement Sci; 2017 Nov; 12(1):129. PubMed ID: 29132380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of antiretroviral and tuberculosis therapies on CD4
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
    Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of individuals requiring antiretroviral therapy and TB treatment.
    Cohen K; Meintjes G
    Curr Opin HIV AIDS; 2010 Jan; 5(1):61-9. PubMed ID: 20046149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of HIV diagnosis in children with tuberculosis managed at a referral hospital in Cape Town, South Africa.
    Byamungu LN; du Preez K; Walters E; Nachega JB; Schaaf HS
    Int J Tuberc Lung Dis; 2018 May; 22(5):488-495. PubMed ID: 29663952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with Mortality of TB/HIV Co-infected Patients in Ethiopia.
    Teklu AM; Nega A; Mamuye AT; Sitotaw Y; Kassa D; Mesfin G; Belayihun B; Medhin G; Yirdaw K
    Ethiop J Health Sci; 2017 Feb; 27(Suppl 1):29-38. PubMed ID: 28465651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of rapid and successful integration of HIV diagnosis and care into tuberculosis services in Benin.
    Ferroussier O; Dlodlo RA; Capo-Chichi D; Boillot F; Gninafon M; Trébucq A; Fujiwara PI
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1405-10. PubMed ID: 24125442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
    Herce ME; Morse J; Luhanga D; Harris J; Smith HJ; Besa S; Samungole G; Kancheya N; Muyoyeta M; Reid SE
    BMC Infect Dis; 2018 Oct; 18(1):536. PubMed ID: 30367622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
    Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
    Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.
    Han SH; Zhou J; Lee MP; Zhao H; Chen YM; Kumarasamy N; Pujari S; Lee C; Omar SF; Ditangco R; Phanuphak N; Kiertiburanakul S; Chaiwarith R; Merati TP; Yunihastuti E; Tanuma J; Saphonn V; Sohn AH; Choi JY;
    HIV Med; 2014 Feb; 15(2):77-85. PubMed ID: 23980589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.